I don't really understand the need or the timing of the CR but I can't tell you how excited I am about the fact that Imugene have just licensed their very own Allogeneic CAR T. I think the CR has actually overshadowed the news of this acquisition which is pretty unfortunate because this is a massive, massive play. Not to mention a massive, massive vote of confidence in CF33.
No-one else in the world has anything like this.
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy, page-419
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $422.5M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |